Clinical Trial

Integrated Diagnostics for Early Diagnosis of Liver Disease

Study acronym: ID LIVER
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism (SNP) analysis and faecal microbiome analysis. The Investigators will improve diagnosis of liver fibrosis compared to the current available diagnostic tools.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-12-07; most recent amendment 2026-02-05.
Trial Details
NCT Number NCT04666402
Lead Sponsor Manchester University NHS Foundation Trust
Collaborators: University of Manchester, University of Nottingham, Innovate UK
Conditions Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Alcoholic Liver Disease, Liver Fibroses
Enrollment 1,200 participants
Start Date 2020-10-21
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09